Chromosome 9, which is often partially or fully reduced to homozygosity in bladder cancer cells, harbors several tumor suppressor loci including deleted in bladder cancer chromosome region 1 (DBCCR1) at 9q32-33. To study DBCCR1 function, stable cell lines, inducible for DBCCR1 expression by tetracycline, were made, but the DBCCR1 protein was not expressed at detectable levels. To understand the fate of DBCCR1-expressing cells, human bladder tumor cells were transiently transfected with an expression vector containing DBCCR1 fused to enhanced green fluorescent protein (EGFP). Initially, DBCCR1-EGFP-expressing cells demonstrated diffuse cytoplasmic green fluorescence with nuclear exclusion patterns. After time, the intensity level of green fluorescence increased and a granular distribution of protein became visible in the cells. At this point, cells rounded up and detached from the tissue culture dish. Cells transfected with a control vector, containing only EGFP, and partial DBCCR1-EGFP fusion constructs did not demonstrate this behavior. DBCCR1-mediated cell death in cultured tumor cells was independent of caspase-3 activation and did not result in detectable DNA strand breaks by TUNEL staining that are hallmarks of the classical apoptotic pathway.
Introduction
Numerous chromosomal alterations have been reported in transitional cell carcinomas (TCCs), which are tumors originating in the transitional cell epithelium, or urothelial lining of the bladder. Chromosome 9 is the most frequent target for allelic loss with 9p and/or 9q deletions found in more than 60% of both superficial and invasive bladder cancers (Cairns et al., 1993; Devlin et al., 1994; Keen and Knowles, 1994; Ruppert et al., 1993) . A tumor suppressor gene, deleted in bladder cancer chromosome region 1 (DBCCR1), has been identified at chromosome 9q32-33 based on loss of heterozygosity (LOH) studies of human bladder tumor specimens (Habuchi et al., 1997 (Habuchi et al., , 1998 . Habuchi et al. (1998) also demonstrated that DBCCR1 mRNA was absent from 5 of 10 tested bladder tumor cell lines. However, the addition of 5 0 aza-2 0 -deoxycytidine to cultured T-24, 609CR, and 5637 bladder tumor cells resulted in the re-expression of DBCCR1 mRNA supporting the hypothesis that DBCCR1 expression is silenced by hypermethylation. The results from a clinical study, conducted by Habuchi et al. (2001) , also support this hypothesis. A total of 20 CpG sites from the DBCCR1 5 0 -island regions were evaluated in 69 bladder tumor (from 45 patients) and 21 normal urothelial specimens for hypermethylation status. In all, 52% (36 of 69) of bladder tumors demonstrated patterns of abnormal hypermethylation without correlation to tumor grade or stage, suggesting that DBCCR1 silencing by hypermethylation may be one of the earliest events in the process of bladder carcinogenesis.
In addition to LOH studies, evidence supporting the hypothesis that DBCCR1 is a tumor suppressor gene includes chromosome copy number changes detected by fluorescence in situ hybridization (FISH) (Stadler et al., 2001) , absence of DBCCR1 mRNA expression in tumor cell lines and bladder tumors, and the existence of a bladder tumor (Nishiyama et al., 1999) and a bladder tumor cell line with homozygous deletions at the DBCCR1 locus (9p33) (Fujiwara et al., 2001) .Transfection and expression of DBCCR1 in NIH/3T3 cells resulted in an increase in the proportion of cells in the G1 phase of the cell cycle (Nishiyama et al., 2001) . This phenomenon was observable only under serum starvation conditions and the mechanism of action remains unclear.
Here we present data on expression of DBCCR1 in bladder tumor cell lines that further supports its function as a tumor suppressor gene. Our results indicate that DBCCR1 expression is incompatible with in vitro tumor cell growth and acts to induce cell death in cultured tumor cells, which is not of the classic apoptotic type.
Results

Restoration of DBCCR1 expression in bladder tumor cell lines
Several attempts were made to establish stable DBCCR1-expressing cell lines (UMUC3, T-24, and MBT-2) using the cytomegalovirus (CMV)-promoterdriven mammalian expression plasmid pcDNA3 (InVitrogen) by selection with Geneticin. UMUC3 and T-24 are human bladder tumor cell lines and MBT-2 cells are derived from a mouse bladder tumor. DBCCR1 expression is present in UMUC3 cells, but not T-24 cells (Habuchi et al., 1998) . We confirmed these results, and determined that MBT-2 cells do not have endogenous DBCCR1 expression by RT-PCR analysis. In each instance, Geneticin resistant lines were established in each cell type, but hemagglutinin (HA)-tagged DBCCR1 protein could not be detected.
To circumvent the paradox of clonal selection for cells expressing a gene expected to have a negative impact on cellular proliferation, an induction strategy, using a two plasmid tetracycline-induction system to control timing and level of gene expression, was attempted. Stable cell lines were designated with the Tet-On HA-DBCCR1 name.
Protein analysis on MBT-2, UMUC3, and T-24 TetOn HA-DBCCR1 stable cell lines demonstrated HA-DBCCR1 protein was not expressed at detectable levels. The same cell cultures initially positive for DBCCR1 expression became negative for DBCCR1 protein expression. Figure 1 demonstrates this result for the MBT-2 Tet-On HA-DBCCR1 cell line. Western blot detection with anti-HA antibody on protein isolated from induced and noninduced cell cultures demonstrated the absence of HA-DBCCR1 protein expression. HA-DBCCR1 protein was only detected in MBT-2 cells transiently transfected with pcDNA3 containing HA-DBCCR1. HA-DBCCR1 protein was also not detectable by immunocytochemical means (data not shown). This strategy to make stable, inducible HA-DBCCR1-expressing cell lines was also unsuccessful in the T-24 and UMUC3 cell lines.
DBCCR1-EGFP constructs
The previous experiments show expression of DBCCR1 is not compatible with in vitro tumor cell growth. To understand what specifically happens to DBCCR1-expressing tumor cells, HA-tagged DBCCR1 was fused to enhanced green fluorescent protein (EGFP) in the mammalian expression vector pcDNA3 (InVitrogen). This strategy allowed for DBCCR1-EGFP-expressing cells to be viewed, in live culture, by fluorescence microscopy.
Confluent UMUC3 cells were transiently transfected with full-length DBCCR1-EGFP or EGFP control. At 12, 14, 16, 18, 20 , and 24 h after transfection, the same 10 fields of cells were observed and photographed. Cells expressing DBCCR1-EGFP initially exhibited patterns of diffuse cytoplasmic green fluorescence with nuclear exclusion. Time course images (Figure 2a) demonstrated that over the 12 h observation period, the intensity levels of green fluorescence increased as granular protein (25 cm 2 ) confluent UMUC3 cells were transiently transfected with the full-length DBCCR1-EGFP. At 12, 14, 16, 18, 20 , and 24 h post-transfection, the same fields of cells were observed by immunofluorescence microscopy and photographed (left column). The corresponding phase images from each time point were also recorded (right column). (b) Flasks of (25 cm 2 ) confluent UMUC3 cells were transiently transfected with EGFP. At 12, 14, 16, 18, 20 , and 24 h post-transfection, the same fields of cells were observed by immunofluorescence microscopy and photographed (left column). The corresponding phase images from each time point were also recorded (right column) aggregates became visible. After this point, cells rounded up and detached from the tissue culture dish. Cells that had detached from the dish were later collected and seeded into a new tissue culture dish, but DBCCR1-EGFP-expressing cells were not able to reattach and establish themselves. DBCCR1-EGFP transfected into the T-24 (human bladder tumor) and NIH-3T3 (mouse fibroblast) cells had the same lethal affect. Figure 2b demonstrates that expression of control EGFP in UMUC3 cells had no affect on cell viability and did not result in toxicity to the cells. Consequently, it was determined that DBCCR1 expression resulted in cultured bladder tumor cell death.
To ensure cellular localization of the DBCCR1-EGFP fusion protein was consistent to that of DBCCR1, mammalian expression (pcDNA3) constructs containing HA-tagged DBCCR1 were transiently transfected into T-24, UMUC3, NIH-3T3, and MBT-2 cells. Immunocytochemical staining with anti-HA antibody demonstrated a cytoplasmic distribution pattern of DBCCR1 in each cell type consistent with DBCCR1-EGFP distribution.
Two DBCCR1 deletion constructs, with amino terminal 305 amino acids (DBCCR1-5 0 305-EGFP) and carboxy terminal 572 amino acids of DBCCR1 (DBCCR1-3 0 572-EGFP), were fused to EGFP in the pcDNA3 expression vector. For simplicity, constructs were named N-DBCCR1-EGFP and C-DBCCR1-EGFP, respectively. In time course experiments, expression of DBCCR1-EGFP deletion constructs did not result in the phenotype observed in cells expressing full-length DBCCR1, nor did they demonstrate any adverse affects and remained as viable as cells expressing the EGFP control (data not shown).
DBCCR1-EGFP-expressing cells are propidium iodide positive
Propidium iodide (PI), a fluorescent DNA binding dye, can be used to stain cells that lack membrane integrity and thus identify viable (negatively stained) and nonviable (positively stained) cells. UMUC3 cells were transfected with DBCCR1-EGFP containing expression plasmids and 48 h post-transfection, PI was added to the tissue culture media (0.1 mg/ml) After 10 min, the media containing the detached cell population was collected, pelleted, resuspended in 100 ml of complete media and dropped onto glass slides for examination. The cells remaining attached in the dish were given fresh media.
Bax transfected cells that had rounded up and detached stained positive for PI, while Bax transfected cells that remained attached in the dish (after the media change) did not stain positive for PI (data not shown). DBCCR1-EGFP cells that had rounded up and detached from the tissue culture dish also stained positive for PI ( Figure 3 , row A), while the small population of cells positive for DBCCR1-EGFP expression that remained attached to the tissue culture dish did not stain positive for PI (row B). It can be noted that the plasmid DNA from the transfection is also visible in attached cells and on the tissue culture dish with the addition of PI. This assay emphasizes, at the single cell level, that expression of DBCCR1 induces cell death.
DBCCR1 mediates TUNEL-negative programmed cell death (PCD)
To determine whether DBCCR1 expression induced TUNEL-positive apoptosis in tumor cell cultures, terminal deoxynucleotide transferase (TdT), which catalyzes polymerization of TMR red labeled nucleotides to free 3 0 -OH DNA ends in a template-dependent manner, was used to label DNA strand breaks that occur during apoptosis. TUNEL-positive cells, with incorporated TMR red labeled nucleotides, were detected and visualized by fluorescence microscopy.
TUNEL was performed on UMUC3 cells transfected with full-length DBCCR1-EGFP, 28 h post-transfection. Cells expressing DBCCR1, regardless of their morphological appearance, were negative for TUNEL staining. Figure 4a shows DBCCR1-EGFP-expressing cells are negative for TUNEL staining. In the same field (panel b) a TUNEL-positive (apoptotic) cell can be seen. Nuclei were counter-stained by 4 0 ,6-diamidino-2-phenylindole (DAPI) (panel c).
TUNEL was also performed on DBCCR1-EGFPpositive UMUC3 cells that had rounded up and detached from the tissue culture dish 48 h after transfection. These cells were collected and cytocentrifuged onto glass slides. These DBCCR1-EGFP-expressing cells were all TUNEL negative (Figure 4d-f) . The results from these experiments demonstrated that expression of DBCCR1 in cultured bladder tumor cells resulted in cell death, but not in detectable DNA strand breaks. TUNEL assays were repeated and identical results were achieved.
DBCCR1 mediates caspase-3-independent cell death
The apoptotic process is a highly regulated event that ultimately leads to the activation of cysteine aspartatespecific proteases, called caspases, of which there are two categories. Upstream or initiator caspases, which start the caspase cascade program, and downstream or effector caspases, which are responsible for actual cell damage and destruction. Caspase-3 is considered the main effector caspase in the destruction phase of apoptosis (Creagh and Martin, 2001) . The presence of active caspase-3 was investigated in cells undergoing DBCCR1-mediated death using antiactive caspase-3 antibody, which recognizes the cleaved or active form of caspase-3.
UMUC3 cells, transfected with mammalian expression plasmid containing proapoptotic Bax, were used as a positive control for caspase-3 activity 24 h posttransfection. Figure 5 demonstrates cells positive for active caspase-3. These cells appear to have classic apoptotic morphology, visible in the phase-contrast field, as well as highly fragmented nuclei, visible with DAPI counterstaining.
In parallel experiments, UMUC3 cells transiently expressing DBCCR1-EGFP were immunostained for active caspase-3 24 and 48 h post-transfection. Staining was performed on cells fixed in tissue culture dishes, as well as on cytospin preparations of cells that had been collected from the media 48 h post-transfection to assay the population of detached dying, or dead cells. Cells undergoing DBCCR1-mediated death were not positive for active caspase-3 ( Figure 6 ). Panels a and b show cells positive for DBCCR1-EGFP, at 24 and 48 h posttransfection, respectively. Antiactive caspase-3 immunostaining and DAPI counterstaining of the same field 
Discussion
An initial goal in the study of DBCCR1 function was to restore expression in bladder tumor cell lines and determine its effect on tumorigenicity. As work progressed, it became apparent that DBCCR1 could not be studied using conventional models because its expression was incompatible with in vitro cell proliferation.
DBCCR1 was hypothesized to have an important role in urothelial tumorigenesis based on LOH analysis of human bladder tumors. The initial, and rather straightforward, approach was to use the tetracycline-induction system and establish stable human bladder tumor cells lines with inducible HA-tagged DBCCR1 expression. Since there are no anti-DBCCR1 antibodies, DBCCR1 was fused to the HA epitope for immunological detection. It was hypothesized that tumorigenic characteristics of tumor cell lines, such as proliferation rates, growth in soft agar, and tumor formation in nude mice, would be blocked or decreased during DBCCR1 expression.
The tetracycline-induction system has been used successfully to induce expression of tumor and growth suppressor genes such as PTEN (Weng et al., 1999) , p21
waf1 (Li et al., 1997) , and pRb2/p130 (Howard et al., 2000) in order to study the function and mechanism of action of the gene products. Our work demonstrated that cultured tumor cells (UMUC3, T-24, and MBT-2) are not able to stably express detectable levels of HA-DBCCR1 protein by either constitutive or inducible strategies.
An alternative assay was developed, and the reason why tumor cell lines fail to express DBCCR1 protein became evident. DBCCR1 was fused at the carboxy end to EGFP in the mammalian expression vector pcDNA3. Using this expression vector, cultured tumor cells could be transfected with DBCCR1-EGFP, or EGFP alone, and observed over time in culture. All described and photographed cells are UMUC3 human bladder tumor cells but identical results were achieved in T-24 and NIH-3T3 cells.
DBCCR1-EGFP-positive cells were tracked over a 12-h period beginning 12 h post-transfection. In this time frame, the lethal effects of DBCCR1-EGFP expression on cultured tumor cells was observed and recorded ( Figure 2a) . Cells expressing DBCCR1 early in time course are healthy in appearance and have a diffuse cytoplasmic distribution of DBCCR1-EGFP. Within the next 4-6 h the DBCCR1-EGFP fluorescence becomes more intense and granular in appearance. In the remaining 4-6 h, the DBCCR1-EGFP-expressing cells become intense fluorescent spheres and begin to detach from the culture dish. In a separate series of experiments, cells that had detached by 24 h post-transfection were collected and transferred to a new tissue culture flask. Only nonexpressing cells were able to attach and remain viable in the new flask. (Figures 2a) , or two DBCCR1-EGFP deletion constructs (data not shown), were imaged in the same manner. Expression of EGFP or two DBCCR1-EGFP deletion constructs is not lethal to cultured cells, further emphasizing the fact that the presence of EGFP does not contribute to cell death or toxicity. Detached DBCCR1-EGFP cells also stained positive for PI in cell viability assays (Figure 3) , demonstrating, at the single cell level, that DBCCR1 expression is lethal to cultured tumor cells.
UMUC3 cells transfected with EGFP control vector
The data presented here illustrate several important points. Namely, that the expression of DBCCR1 in cultured cells results in selection against DBCCR1-positive cells, which alters the cell population in a long-term, stable culture. This points out that caution must be taken when interpreting results of transient and stable transfection experiments. Resistance to antibiotics from cotransfected resistance genes in selected cell lines does not guarantee expression of the gene of interest at the protein level. Similarly, data from an efficient transient transfection that eliminates transfected cells from the cell population and enriches for nonexpression could easily be misinterpreted, if the status of protein expression on an individual cell basis is not observed. Lastly, because of the lethal affect of DBCCR1 expression on cultured cells, future studies focusing on DBCCR1 function will have to be approached using alternative techniques. Figure 6 Antiactive caspase-3 immunostaining in UMUC3 cells expressing DBCCR1-EGFP. Cells, attached to tissue culture dishes, were immunostained for active caspase-3 24 h (row a) and 48 h (row b) post-transfection with DBCCR1-EGFP. Detached cells were collected from media, 48 h post-transfection, and used to make cytospin preparations (rows c and d) for the caspase-3 assay. Row a demonstrates healthy DBCCR1-EGFP-expressing cells negative for active caspase-3. Row b demonstrates a rounded up, dying, DBCCR1-EGFP-expressing cell, also negative for active caspase-3, in the same field as a cell positive for active caspase-3 expression. Note the fragmented nuclear morphology of the cell with active caspase-3 expression. Row c demonstrates detached dying, or dead cells, positive for DBCCR1-EGFP, are also negative for active caspase-3 and do not show the fragmented nuclear morphology associated with apoptosis. Apoptotic cells, positive for active caspase-3, were present in cytospin preparations (row d) and often displayed apoptotic fragmented nuclear morphology
DBCCR1-Mediated cell death KO Wright et al
Although protein expression in time course studies was unregulated, driven by the CMV promoter, induction of UMUC3 cell death was specific to expression of the full-length DBCCR1-EGFP protein.
Constitutive overexpression of EGFP or DBCCR1-EGFP deletion proteins did not result in cell death or toxicity. Therefore, DBCCR1 expression, not an overabundance of protein, is lethal to cultured tumor cells. The fact that tetracycline-inducible HA-DBCCR1 stable cell lines were negative for HA-DBCCR1 expression also adds strength to this argument. Presumably, low levels of background gene expression (DBCCR1) during the cell selection process were sufficient to select against cells positive for DBCCR1 protein expression.
DBCCR1-mediated cell death was further characterized. PCD, often synonymous with the term apoptosis, is organized, energy dependent, and often defined by distinct morphologic changes in the cell such as nuclear condensation and fragmentation and cytoplasmic blebbing (Tang and Porter, 1996; Kaufmann and Hengartner, 2001 ). Chromatin damage and DNA cleavage also occur with nuclear collapse (Compton, 1992) . To determine if DBCCR1 cell death was mediated through the apoptotic pathway, TUNEL staining was performed on UMUC3 cells 28 h after transfection with DBCCR1-EGFP (Figure 4 ). DBCCR1-EGFP-expressing cells were not TUNEL positive. A small population of nontransfected cells were apoptotic and TUNEL positive and served as a positive control. Detached DBCCR1-EGFP-expressing cells were also TUNEL negative.
Activation of caspase-3 during the death process was also investigated. Apoptosis is a highly regulated process that ultimately leads to the activation of cysteine aspartate-specific proteases, called caspases. In all, 11 human caspase family members have been identified which are categorized into two main subgroups; inflammatory and apoptotic caspases. These proteins are expressed as proenzymes that undergo cleavage events to become completely activated proteases. Specific caspases have been recognized for their role in cleavage of key proteins during the apoptotic cell death cascade (Nicholson and Thornberry, 1997) and caspase-3 is recognized as a crucial effector caspase for the apoptotic process.
Bax, a proapoptotic member of the Bcl-2 family, was used to induce apoptosis in UMUC3 cells as a positive control. At 24 h post-transfection, many Bax expressing UMUC3 cells stained positive for active caspase-3. The majority of positive cells illustrated highly fragmented nuclei and classic nuclear morphology demonstrating UMUC3 cells were capable of undergoing caspase-3-dependent apoptosis and were an appropriate model system for the assay.
Active caspase-3, however, was not detectable in UMUC3 cells positive for DBCCR1-EGFP expression 24 or 48 h post-transfection. To ensure that the population of dying or dead DBCCR1-EGFP cells was not lost, detached cells were collected from media and cytospun onto glass slides for antiactive caspase-3 immunostaining. Again, cells positive for DBCCR1-EGFP expression were not positive for active caspase-3 staining, strengthening the conclusion that DBCCR1 does not mediate a caspase-dependent apoptotic death process.
Classically, all PCD was categorized as caspasedependent apoptosis, but there is now evidence suggesting the existence of alternative pathways of PCD, classified as nonapoptotic or nonclassical PCD. These processes are also energy dependent and result in dying cells displaying some or many of the same morphological characteristics, which have become hallmarks of the apoptotic process. Leist and Jaattela (2001) review recent work, which has demonstrated the existence of caspase-independent PCD, which may be evolutionarily conserved. They describe four different patterns of cell death as apoptosis, apoptosis-like PCD, necrosis-like PCD, and accidental necrosis/cell lysis, based on morphology and fate of the dying cell. Apoptosis, characterized as caspase-dependent PCD, is illustrated by morphological changes observed in dying cells such as membrane blebbing, chromatin condensation, nuclear fragmentation, and DNA cleavage. Apoptosis can be arrested in the cell by blockage of a specific signal or activity (caspases) of the apoptotic pathway.
Apoptosis-like PCD encompasses many PCD pathways that occur in the absence of caspase activation and cannot be simplified into one concise definition. Cells undergoing apoptosis-like PCD may demonstrate chromatin condensation that is less dense or less complete compared to what is observed in typical apoptosis. Other apoptotic characteristics, in some proportion or number, may also be observed during this type of PCD. Most importantly, the process of apoptosis-like PCD cannot be inhibited by interruption of a specific apoptosis signal or activity, such as caspase activity. Based on the data collected, it is possible that DBCCR1-mediated cell death falls into this category of apoptosislike PCD. DBCCR1-EGFP-expressing, or dead, cells do not display DNA strand breaks or active caspase-3.
The results of these studies do not fully define the pathway of DBCCR1-mediated cell death but are nonetheless important. For the first time, the fate of cells expressing DBCCR1 has been demonstrated. The findings of these studies conclusively show that DBCCR1 does induce cultured tumor cell death, a role which is compatible with the hypothesis that DBCCR1 is a tumor suppressor gene with an important role in urological cancers. The fact that DBCCR1 appears to mediate a nonclassical death pathway may be important for future research. If the expression of this gene could be understood and manipulated, it might offer an attractive therapeutic option for cancer treatments.
Materials and methods
Tissue culture and cell transfections
The UMUC3, T-24, and NIH-3T3 cell lines were obtained from the ATCC. The mouse bladder tumor cell line MBT-2 (Mickey et al., 1982) was a generous gift of Dr Guan Wu (Department of Urology, University of Rochester). Cell lines were maintained in DMEM (Life Technologies) supplemented with 10% FBS (Sigma) and penicillin/streptomycin antibiotics (Life Technologies). Cells were grown in polystyrene 25 cm 2 dishes and transfected with 3.0 mg of DNA using 30 ml of Lipofectamine transfection reagent (Life Technologies) according to the manufacturer's recommendations for 3 h.
Tetracycline-induction system
HA-DBCCR1 was cloned into the hygromycin selectable inducible mammalian expression vector pTEP4m. pTEP4m-HA-DBCCR1 constructs were transfected into cell lines stably transfected with pUHD172-neo. The plasmid pUHD172-1neo (Gossen et al., 1995) encodes the reverse tetracycline transactivator protein fused with a nuclear localization signal (rtTAnls). In addition to the rtTA-nls gene under, CMV promoter control, this plasmid also encodes neomycin resistance to enable dual selection of stable cell lines. With the addition of tetracycline, or its analog doxycycline, the rtTA binds to the TRE and initiates transcription of the desired gene. Stable cell lines, containing both plasmids, were designated with the Tet-On HA-DBCCR1 name. Tet-On pTEP4M-HA-DBCCR1 stable cell lines were induced with 2 mg/ml doxycycline (Sigma).
Plasmids
The DBCCR1 cDNA was obtained by reverse transcription of total RNA from normal human brain. cDNA was PCR amplified using primers TCGATATCAGCATGAACTG-GAGGTTTGTTG and GAGTCTAGAGGGTTAGCA-GAGTTTGGCTGTC. DBCCR1 cDNA was ligated into modified pcDNA3 vector (InVitrogen) downstream of a sequence that encodes an initiator methionine, 6-histidine residues (6-His) and a nine amino acid, influenza virus HA epitope tag (YPYDVPDYA) (Sowden et al., 1998) . The pTEP4m plasmid was derived from pMEP4 (Groger et al., 1989) by replacing the metallothionein II A gene promoter with the tetracycline response element and removal of the EpsteinBarr virus origin of DNA replication. The 6HIS-HA-DBCCR1 cDNA sequence was PCR amplified using primers CTCCTCGAGGCTCTAGCATTTAGGTGACAA-TATAG and CTCACGCGTTAATACGACTCACTA-TAGGG and cloned into pTEP4m. DNA sequences and reading frames were verified using 'BigDye' Terminator Sequencing reagent (PE Applied Biosystems). Plasmid pUHD172-1neo (Gossen et al., 1995) encodes the reverse tetracycline transactivator protein fused with a nuclear localization signal (rtTA-nls). A Gateway (InVitrogen) DBCCR1 entry clone was generated by amplification of the HA-DBCCR1 sequence from the pcDNA3-6His-HA-DBCCR1 plasmid using primers containing the attB1 and attB2 recombination sites followed by a BP reaction to insert the PCR product into the pDONR201 entry plasmid. The EGFP cDNA was PCR amplified from EGFP-C1 plasmid (Clontech) and ligated into pcDNA3. The resulting plasmid was linearized and the Gateway rfB conversion (InVitrogen) cassette inserted at the 5 0 end of the EGFP cDNA sequence. The HA-DBCCR1 cDNA was transferred from pDONR201 entry plasmid to pcDNA3-rfB-EGFP expression plasmid by an LR reaction according to the manufacturers protocol (InVitrogen).
The Bax plasmid (Easton et al., 1997) used to induce apoptosis for the active caspase-3 assays, pcDNA3-Bax-Flag, was shared with us by Dr Robert Freeman (University of Rochester, Rochester, New York, USA), who obtained it from Dr Eugene Johnon of Washington University, St Louis.
Immunoblotting
Tissue culture cells were scraped from plates, washed and pelleted in cold phosphate-buffered saline (PBS). Cells were lysed in 1 Â Reporter Lysis Buffer (Promega) and proteins were precipitated with 2.5 volumes of acetone, at À851C, and pelleted by centrifugation. Protein was separated on 7.5% denaturing SDS-polyacrylamide gel and transferred to nitrocellulose membranes. Membranes were blocked with 5% dry milk in tris-buffered saline (pH 7) with 1% Tween 20. HA-DBCCR1 fusion proteins were detected using anti-HA mouse monoclonal antibody (CoVance) at 1 : 2000 dilution. HA-DBCCR1-EGFP fusion proteins were detected with mouse monoclonal anti-GFP antibody (CoVance) at 1 : 20,000 dilution. Secondary antibody was horseradish peroxidase-conjugated horse anti-mouse (Vector). Enhanced chemiluminescence (ECL) Western blotting detection reagents (Amersham Pharmacia Biotech) were used to visualize blots captured on X-OMAT LS (Kodak) film.
Time course imaging
Live cell cultures, transiently transfected with EGFP fusion constructs were imaged with inverted fluorescence microscopy. Cell positions were recorded and imaged at 12, 14, 16, 18, 20 , and 24 h post-transfection.
Cell viability assay
UMUC3 cells were grown in complete DMEM minus phenol red (to minimize background red fluorescence). At 48 h posttransfection, with expression plasmids containing either Bax or DBCCR1-EGFP, PI was added to the media at a final concentration of 0.1 mg/ml. After 10 min, the media (containing detached cells) were removed, pelleted, and resuspended in 100 ml of complete DMEM (minus phenol red). A measure of 10 ml was dropped onto glass slides, coverslipped, and photographed. Fresh media were added to the cells remaining in the tissue culture dish.
TUNEL assay
Cell cultures were rinsed with 1 Â PBS and fixed, for 1 h at room temperature, with 1% paraformadehyde. Supernatants from cell cultures were collected, pelleted and cytocentrifuged (CYTO-TEK, Miles Scientific) onto glass slides. Cells were lysed with PBS þ 0.2% Triton-X and then incubated with TUNEL reaction mixture (Boehringer Mannheim) at 371C for an hour. Cells were washed in blocking solution (PBS þ 1% BSA), and PBS. DAPI mounting media (Vectashield) was applied to visualize nuclei.
Active caspase-3 assay
Cells were fixed in tissue culture dishes or cytocentrifuged as described. Cells were lysed with PBS þ 0.2% Triton-X and blocked (PBS þ 0.1%Tween 20 þ 5% Normal Goat Serum) before incubation with 1 : 150 dilution of antiactive caspase-3 antibody (Promega). Cells were then incubated with 1 : 200 dilution Texas-red-conjugated goat anti-rabbit secondary antibody (Calbiochem). DAPI mounting media (Vectashield) was applied to visualize nuclei.
